← Back to Search

Behavioural Intervention

Social Dance Therapy for Early Alzheimer's Disease

N/A
Recruiting
Led By Madeleine Hackney, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Single or multi-domain amnestic MCI (both subtypes are at high risk for progression to AD)
Amnestic mild cognitive impairment (MCI) as per AD Neuroimaging Initiative (ADNI) criteria
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 12 months
Awards & highlights

Study Summary

This trial will use partnered, rhythmic rehabilitation, or PRR, as an intervention to target cardiovascular, social, and motor-cognitive domains important to Alzheimer's disease (AD). PRR is a moderate intensity, cognitively-engaging social dance that is safe and results in no injurious falls. This study is a 12-month long Phase II single- blind randomized clinical trial using PRR in 66 patients with early AD.

Who is the study for?
This trial is for individuals with early Alzheimer's Disease who can walk unaided, have a certain level of cognitive function and memory concern, completed at least six grades of education or have a solid work history, are not very physically active, and willing to commit to a year-long research program. Those with severe mental health issues, recent hospitalization or conditions that could interfere with the study cannot participate.Check my eligibility
What is being tested?
The trial tests Partnered Rhythmic Rehabilitation (PRR), which is social dance aimed at improving cardiovascular health, motor-cognitive functions and social interaction against group walking. It's a 12-month Phase II trial where participants do biweekly sessions for three months followed by weekly sessions for nine months.See study design
What are the potential side effects?
Previous studies suggest PRR classes are safe without causing injurious falls. However, as it involves physical activity there may be general risks associated such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have mild cognitive impairment that affects my memory.
Select...
I have been diagnosed with mild memory loss (MCI) according to ADNI standards.
Select...
I can perform daily activities without significant assistance.
Select...
I can walk more than 10 feet on my own without help.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attrition
Change in Acceptability
Change in Four Square Step Test (FSST) Time
+1 more
Secondary outcome measures
Change in 6 Minute Walk Test (6MWT) Distance
Change in Backward Gait Speed
Change in Body Position Spatial Task (BPST)
+17 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Partnered Rhythmic Rehabilitation (PRR)Experimental Treatment1 Intervention
Participants in this study are will receive the PRR intervention. Participants will have two phases of intervention. In the three-month Training phase, participants will be assigned to 20, biweekly (90-minute) lessons over 12 weeks. In the nine-month Maintenance phase, participants will attend weekly lessons at least 3 times per month.
Group II: Group walking (WALK)Active Control1 Intervention
Participants in this study are will receive the WALK intervention. Participants will have two phases of intervention. In the three-month Training phase, participants will be assigned to 20, biweekly (90-minute) lessons over 12 weeks. In the nine-month Maintenance phase, participants will attend weekly lessons at least 3 times per month.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,662 Previous Clinical Trials
28,004,548 Total Patients Enrolled
Emory UniversityLead Sponsor
1,635 Previous Clinical Trials
2,560,065 Total Patients Enrolled
Madeleine Hackney, PhDPrincipal InvestigatorEmory University

Media Library

Group walking (WALK) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04029623 — N/A
Alzheimer's Disease Research Study Groups: Group walking (WALK), Partnered Rhythmic Rehabilitation (PRR)
Alzheimer's Disease Clinical Trial 2023: Group walking (WALK) Highlights & Side Effects. Trial Name: NCT04029623 — N/A
Group walking (WALK) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04029623 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the current cohort of participants restricted to those aged fifty-five or younger?

"Enrolment in this trial is restricted to those between the ages of 50 and 80. In comparison, there are 23 active clinical trials for minors under 18 and 538 studies recruiting senior citizens older than 65."

Answered by AI

What primary goals have been set forth by this research endeavor?

"This evaluation will span from the Baseline to 3 months and 12 months, aiming to gauge an alteration in Acceptability. Secondary objectives include tracking any changes in Spatial 1-Back Test Score (as assessed by EXAMINER), Reverse Corsi Blocks Levels Completed, and Lawton Instrumental Acitivities of Daily Living (IADL) Score."

Answered by AI

How many participants is this clinical trial enrolling?

"Confirmed. Clinicaltrials.gov points to the fact that this medical study, which was initiated on October 29th 2019, is currently recruiting patients. 66 participants must be sourced from only 1 site for the trial's completion."

Answered by AI

Are there still opportunities for participants in this experiment?

"Affirmative. Clinicaltrials.gov reports that this clinical trial, which first went public on October 29th 2019 is still searching for participants to join the study. This medical undertaking requires 66 patients to be recruited from a single site."

Answered by AI

Who is eligible to enroll in this research project?

"This clinical trial seeks 66 individuals between 50 and 80 years of age who have been diagnosed with Alzheimer's disease. Participants must also meet the following criteria: evidence of memory impairment, an MMSE score between 24 - 30, CDR= 0.5, preserved general functioning ability (including walking), 6+ grades of education or suitable work experience to exclude intellectual disabilities, less than 150 minutes/week moderate intensity exercise or 75 minutes/week vigorous intensity activity without being enrolled in a structured program within 3 months prior and no hospitalizations within the last 2 months."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
How old are they?
65+
What site did they apply to?
Emory University
What portion of applicants met pre-screening criteria?
Did not meet criteria
~12 spots leftby Apr 2025